CRSP
Price
$83.99
Change
-$2.20 (-2.55%)
Updated
Feb 23, 6:59 PM EST
65 days until earnings call
DNA
Price
$1.32
Change
+$0.02 (+1.53%)
Updated
Feb 23, 6:59 PM EST
4 days until earnings call
Ad is loading...

Analysis and predictions CRSP vs DNA

Header iconCRSP vs DNA Comparison
Open Charts CRSP vs DNABanner chart's image
CRISPR Therapeutics AG
Price$83.99
Change-$2.20 (-2.55%)
Volume$1.14M
CapitalizationN/A
Ginkgo Bioworks Holdings
Price$1.32
Change+$0.02 (+1.53%)
Volume$5.13M
CapitalizationN/A
View a ticker or compare two or three
CRSP vs DNA Comparison Chart

Loading...

DNADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CRSP vs. DNA commentary
Feb 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and DNA is a Hold.

COMPARISON
Comparison
Feb 25, 2024
Stock price -- (CRSP: $83.99 vs. DNA: $1.32)
Brand notoriety: CRSP and DNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 91% vs. DNA: 45%
Market capitalization -- CRSP: $6.74B vs. DNA: $2.82B
CRSP [@Biotechnology] is valued at $6.74B. DNA’s [@Biotechnology] market capitalization is $2.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $550.21B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileDNA’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • DNA’s FA Score: 0 green, 5 red.
According to our system of comparison, CRSP is a better buy in the long-term than DNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNA’s TA Score shows that 6 TA indicator(s) are bullish.

  • DNA’s TA Score: 6 bullish, 3 bearish.

Price Growth

CRSP (@Biotechnology) experienced а +2.15% price change this week, while DNA (@Biotechnology) price change was -10.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.03%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +38.88%.

Reported Earning Dates

CRSP is expected to report earnings on Apr 30, 2024.

DNA is expected to report earnings on May 13, 2024.

Industries' Descriptions

@Biotechnology (+2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CRSP with price predictions.
OPEN
A.I.dvisor published
a Summary for DNA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRSP($6.74B) has a higher market cap than DNA($2.82B). CRSP YTD gains are higher at: 34.169 vs. DNA (-21.893). CRSP has higher annual earnings (EBITDA): -402.88M vs. DNA (-658.08M). CRSP has more cash in the bank: 1.74B vs. DNA (1.05B). CRSP has less debt than DNA: CRSP (242M) vs DNA (404M). DNA has higher revenues than CRSP: DNA (315M) vs CRSP (170M).
CRSPDNACRSP / DNA
Capitalization6.74B2.82B239%
EBITDA-402.88M-658.08M61%
Gain YTD34.169-21.893-156%
P/E Ratio20.92N/A-
Revenue170M315M54%
Total Cash1.74B1.05B166%
Total Debt242M404M60%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNA
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Ad is loading...
DNADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DRSVX21.250.13
+0.62%
Foundry Partnersl Sm Cp Val Inv
DCREX11.600.04
+0.35%
Dunham Real Estate Stock C
GTLOX23.030.05
+0.22%
Glenmede Quant US Large Cap Core Eq
PPNPX13.03-0.01
-0.08%
Principal SmallCap Growth I R5
JAMRX73.81-0.17
-0.23%
Janus Henderson Research T

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been loosely correlated with SANA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRSP jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-2.55%
SANA - CRSP
59%
Loosely correlated
+2.41%
AGIO - CRSP
54%
Loosely correlated
+10.78%
BLUE - CRSP
53%
Loosely correlated
+5.93%
SGMO - CRSP
52%
Loosely correlated
+2.73%
DNA - CRSP
51%
Loosely correlated
N/A
More